Senior insider sale
IONIS PHARMACEUTICALS INC — senior position signals high conviction
$827.4K
10K shares
What this filing means
PARSHALL B LYNNE plans to sell 10K shares of IONIS PHARMACEUTICALS INC valued at approximately $827.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2026ACC: 0001972481-26-000053
10K
Shares to sell
$827.4K
Approx. market value
78.32K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
1/15/2017
78.32KTotal acquired78.32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2017 | Restricted Stock Units Equity Compensation | 78.32K | — |
| Total | 78.32K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
10K
Market value
$827.4K
2/11/2026
Total
Units
10K
Value
$827.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/11/2026 | 10K | $827.4K | Nasdaq | Planned |
| Total | 10K | $827.4K | ||